Journal
PSYCHO-ONCOLOGY
Volume 16, Issue 4, Pages 352-357Publisher
WILEY
DOI: 10.1002/pon.1090
Keywords
cognitive function; advanced cancer; reliability; validity
Ask authors/readers for more resources
Aim: The aim of the present study was to validate the Greek version of the MMSE in advanced-cancer patients attending a palliative care unit. Methods: The sample consisted of 103 advanced-cancer patients. The questionnaire was completed at baseline and three days later. Together with the MMSE, the patients also completed the EORTC QLQ-C30 Cognitive functioning scale, while researchers recorded data on demographic characteristics, disease status and treatment regimen. Results: MMSE had overall Cronbach alpha 0.890. Validity as performed using known-group analysis showed good results. MMSE discriminated well between subgroups of patients differing in disease severity as defined by ECOG performance status. Comparison between the MMSE and the EORTC Cognitive functioning scale was statistically significant (p < 0.05). Conclusion: These psychometric properties of the Greek version of the MMSE confirm it as a valid and reliable measure when administered to patients with advanced cancer. Copyright (c) 2006 John Wiley & Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available